Role of endocannabinoids in the progression of diabetic retinopathy
Authors:
- 17 November 2015
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 32 (3) , 251-259
Abstract
Summary: In the past decades, the role of numerous factors in the pathophysiology of diabetic retinopathy has been explored, following which marked progress has been made in developing several novel therapeutic options, such as anti‐vascular endothelial growth factor, anti‐tumor necrosis factor‐alpha and various other anti‐inflammatory and anti‐angiogenic agents, for the treatment of diabetic retinopathy. However, the involvement of endocannabinoid system in its pathogenesis has not been much explored. This review aims at unveiling every aspect of association of the endocannabinoid system and its interactions with various physiological and pathological pathways to induce disease progression. The various alterations induced by endocannabinoids, such as anandamide and 2‐arachidonylglycerol, in retina during hyperglycaemia clearly demonstrate and verify their involvement in aggravating the pathological conditions, hence leading to the progression of diabetic retinopathy. Exploring this involvement furthermore, in greater depths, might be beneficial in acknowledging and understanding the hidden aspects of the pathogenesis of this complication even better and might provide a therapeutically beneficial alternative target to combat and restrict its progression amongst diabetic patients. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
This publication has 67 references indexed in Scilit:
- Endocannabinoid signaling at the periphery: 50 years after THCTrends in Pharmacological Sciences, 2015
- Endocannabinoid signalling and the deteriorating brainNature Reviews Neuroscience, 2014
- Phosphatidic acid and lipid-sensing by mTORTrends in Endocrinology & Metabolism, 2013
- Pathophysiology of Diabetic RetinopathyISRN Ophthalmology, 2013
- Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their MetabolismPLOS ONE, 2011
- Neurovascular Interaction and the Pathophysiology of Diabetic RetinopathyExperimental Diabetes Research, 2011
- Hyperglycemia induces apoptosis via CB1 activation through the decrease of FAAH 1 in retianl pigment epithelial cellsJournal of Cellular Physiology, 2011
- The endocannabinoid system in obesity and type 2 diabetesDiabetologia, 2008
- Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioningBritish Journal of Pharmacology, 2008
- Effect of Chronic Hyperglycemia on Intraocular Pressure in Patients With DiabetesAmerican Journal of Ophthalmology, 2007